Job Fair Polytechnic University-SJ

Summary

We're excited to learn more about you and your background. Please apply to this requisition so we can review your information and match you with potential opportunities within OcyonBio.

Job description

Company overview

Biosimilar Sciences PR LLC is a leading global biosimilar company headquartered in Aguadilla, Puerto Rico, dedicated to transforming healthcare by expanding access to high-quality, affordable biologic medicines. The company specializes in developing biosimilar therapeutics that are highly similar to already approved reference biologics, with no clinically meaningful differences in safety, purity, or effectiveness. Their portfolio targets critical therapeutic areas including oncology, immunology, and metabolic disorders, with products such as biosimilars for GCSF (Neupogen), PEG-GCSF (Neulasta), Darbepoetin (Aranesp), and Adalimumab (Humira). Backed by strategic partnerships with Biosimilar Solutions and Biosimilar Sciences India LLP, the company operates as a hub for research & development, process optimization, and regulatory expertise. In 2023, Biosimilar Sciences PR LLC received $3.85 million in funding from the Puerto Rico Economic Development Bank to acquire specialized biotechnology equipment and expand manufacturing capacity, positioning Puerto Rico as a key location for biosimilar production in American territory. The company's mission centers on improving patient lives through innovation-driven, patient-focused solutions that bridge healthcare gaps and promote global health equity.